FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,000 | -99.9% | 127 | -99.9% | 0.00% | -100.0% |
| Q4 2016 | $8,181,000 | -6.4% | 163,255 | -2.0% | 0.58% | +3.2% |
| Q3 2016 | $8,740,000 | +24.8% | 166,509 | -1.7% | 0.56% | +16.0% |
| Q2 2016 | $7,006,000 | -62.0% | 169,439 | -62.7% | 0.49% | -70.0% |
| Q1 2016 | $18,451,000 | +2.4% | 454,129 | +4.6% | 1.62% | +21.4% |
| Q4 2015 | $18,016,000 | +106.0% | 434,129 | -23.6% | 1.33% | +281.9% |
| Q3 2015 | $8,746,000 | +57.1% | 568,258 | +153.5% | 0.35% | +4.2% |
| Q2 2015 | $5,567,000 | +8.7% | 224,129 | 0.0% | 0.34% | -15.8% |
| Q1 2015 | $5,121,000 | +22.2% | 224,129 | +44.4% | 0.40% | +13.1% |
| Q4 2014 | $4,192,000 | +138.2% | 155,256 | +3.5% | 0.35% | +86.2% |
| Q3 2014 | $1,760,000 | -24.6% | 150,000 | 0.0% | 0.19% | -17.5% |
| Q2 2014 | $2,333,000 | -20.9% | 150,000 | 0.0% | 0.23% | -26.1% |
| Q1 2014 | $2,949,000 | +32.5% | 150,000 | +13.2% | 0.31% | +16.1% |
| Q4 2013 | $2,225,000 | – | 132,500 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,381,117 | $47,065,000 | 4.14% |
| GREAT POINT PARTNERS LLC | 1,647,753 | $22,937,000 | 3.58% |
| Rock Springs Capital Management LP | 598,000 | $8,324,000 | 0.30% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 136,029 | $1,894,000 | 0.14% |
| FOX RUN MANAGEMENT, L.L.C. | 20,935 | $291,000 | 0.13% |
| Hilltop Holdings Inc. | 39,824 | $554,000 | 0.12% |
| WEXFORD CAPITAL LP | 112,700 | $1,569,000 | 0.10% |
| OXFORD ASSET MANAGEMENT LLP | 296,339 | $4,132,000 | 0.09% |
| Vident Investment Advisory, LLC | 133,272 | $1,855,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 90,000 | $1,253,000 | 0.06% |